Ghost-Managed Medicine : Big Pharma’s Invisible Hands / / Sergio Sismondo.

Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:Manchester : : Mattering Press,, [2018]
©[2018]
Year of Publication:2018
Language:English
Physical Description:1 online resource (231 pages) :; illustrations ;
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993544390204498
ctrlnum (CKB)5590000000430781
(OCoLC)1229912820
(MdBmJHUP)muse95583
(oapen)https://directory.doabooks.org/handle/20.500.12854/48607
(EXLCZ)995590000000430781
collection bib_alma
record_format marc
spelling Sismondo, Sergio, author.
Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo.
Mattering Press 2018
Manchester : Mattering Press, [2018]
©[2018]
1 online resource (231 pages) : illustrations ;
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on print version record.
Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from contract research organizations (that extract data from experimental bodies) to publication planners (who produce ghostwritten medical journal articles) to key opinion leaders (who are sent out to educate physicians about drugs) to patient advocacy organizations (who ventriloquize views on diseases, treatments and regulations), and onward. The goal of this ‘assemblage marketing’ is to establish conditions that make specific diagnoses, prescriptions and purchases as obvious and frequent as possible. While staying in the shadows, companies create powerful markets in which increasing numbers of people become sick and the drugs largely sell themselves. Most agents for drug companies aim to tell the truth, but the truths they tell are drawn from streams of knowledge that have been fed, channeled and maintained by the companies at every possible opportunity. Especially because those companies have concentrated influence and narrow interests, consumers and others should be concerned about how epistemic power is distributed – or ‘political economies of knowledge’ – and not just about truth and falsity of medical knowledge. In pharmaceutical companies’ ideal worlds, medical research, education and marketing would be tightly fused. Doctors trying to educate themselves would turn to companies’ agents, such as researchers and educators sponsored to spread particular messages, local sales reps hired to change doctors’ behaviour, or journalists supplied with news stories. Ghost-Managed Medicine shows that the real world of medicine is not very far from the worlds that the companies want to create. Big Pharma’s many invisible hands are busy throughout medicine, and medicine changes as a result.
English
Pharmaceutical industry Moral and ethical aspects. fast (OCoLC)fst01060163
Drugs Research Moral and ethical aspects. fast (OCoLC)fst00898905
Drugs Marketing Moral and ethical aspects. fast (OCoLC)fst00898841
Drugs Research Moral and ethical aspects.
Drugs Marketing Moral and ethical aspects.
Pharmaceutical industry Influence.
Pharmaceutical industry Moral and ethical aspects.
Electronic books.
Medicine (General)
0-9955277-8-4
language English
format eBook
author Sismondo, Sergio,
spellingShingle Sismondo, Sergio,
Ghost-Managed Medicine Big Pharma’s Invisible Hands /
author_facet Sismondo, Sergio,
author_variant s s ss
author_role VerfasserIn
author_sort Sismondo, Sergio,
title Ghost-Managed Medicine Big Pharma’s Invisible Hands /
title_sub Big Pharma’s Invisible Hands /
title_full Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo.
title_fullStr Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo.
title_full_unstemmed Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo.
title_auth Ghost-Managed Medicine Big Pharma’s Invisible Hands /
title_new Ghost-Managed Medicine
title_sort ghost-managed medicine big pharma’s invisible hands /
publisher Mattering Press
Mattering Press,
publishDate 2018
physical 1 online resource (231 pages) : illustrations ;
isbn 0-9955277-7-6
0-9955277-8-4
genre Electronic books.
genre_facet Electronic books.
illustrated Not Illustrated
oclc_num 1229912820
work_keys_str_mv AT sismondosergio ghostmanagedmedicinebigpharmasinvisiblehands
status_str c
ids_txt_mv (CKB)5590000000430781
(OCoLC)1229912820
(MdBmJHUP)muse95583
(oapen)https://directory.doabooks.org/handle/20.500.12854/48607
(EXLCZ)995590000000430781
carrierType_str_mv cr
is_hierarchy_title Ghost-Managed Medicine Big Pharma’s Invisible Hands /
_version_ 1796649061394153473
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03725cam a22004454a 4500</leader><controlfield tag="001">993544390204498</controlfield><controlfield tag="005">20230621141354.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr||||||||nn|n</controlfield><controlfield tag="008">180725s2018 enk o 00 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0-9955277-7-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5590000000430781</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1229912820</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MdBmJHUP)muse95583</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/48607</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995590000000430781</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MdBmJHUP</subfield><subfield code="c">MdBmJHUP</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sismondo, Sergio,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ghost-Managed Medicine</subfield><subfield code="b">Big Pharma’s Invisible Hands /</subfield><subfield code="c">Sergio Sismondo.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Mattering Press</subfield><subfield code="c">2018</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Manchester :</subfield><subfield code="b">Mattering Press,</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©[2018]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (231 pages) : </subfield><subfield code="b">illustrations ;</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from contract research organizations (that extract data from experimental bodies) to publication planners (who produce ghostwritten medical journal articles) to key opinion leaders (who are sent out to educate physicians about drugs) to patient advocacy organizations (who ventriloquize views on diseases, treatments and regulations), and onward. The goal of this ‘assemblage marketing’ is to establish conditions that make specific diagnoses, prescriptions and purchases as obvious and frequent as possible. While staying in the shadows, companies create powerful markets in which increasing numbers of people become sick and the drugs largely sell themselves. Most agents for drug companies aim to tell the truth, but the truths they tell are drawn from streams of knowledge that have been fed, channeled and maintained by the companies at every possible opportunity. Especially because those companies have concentrated influence and narrow interests, consumers and others should be concerned about how epistemic power is distributed – or ‘political economies of knowledge’ – and not just about truth and falsity of medical knowledge. In pharmaceutical companies’ ideal worlds, medical research, education and marketing would be tightly fused. Doctors trying to educate themselves would turn to companies’ agents, such as researchers and educators sponsored to spread particular messages, local sales reps hired to change doctors’ behaviour, or journalists supplied with news stories. Ghost-Managed Medicine shows that the real world of medicine is not very far from the worlds that the companies want to create. Big Pharma’s many invisible hands are busy throughout medicine, and medicine changes as a result.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01060163</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Moral and ethical aspects.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00898905</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Marketing</subfield><subfield code="x">Moral and ethical aspects.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00898841</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Marketing</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Influence.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books. </subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">0-9955277-8-4</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-29 03:33:10 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2021-01-16 22:18:34 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337579600004498&amp;Force_direct=true</subfield><subfield code="Z">5337579600004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337579600004498</subfield></datafield></record></collection>